Kuban DA - Search Results

1

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. Madsen LT, et al. Among authors: kuban da. J Natl Compr Canc Netw. 2014 Jul;12(7):993-8. doi: 10.6004/jnccn.2014.0096. J Natl Compr Canc Netw. 2014. PMID: 24994920 Free PMC article.

2

Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.

Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Kim JA, et al. Among authors: kuban da. Radiology. 1995 Feb;194(2):545-9. doi: 10.1148/radiology.194.2.7529936. Radiology. 1995. PMID: 7529936

3

The durability of external beam radiation therapy for prostate cancer: can it be identified?

Davis JW, Kolm P, Wright GL Jr, Kuban D, El-Mahdi A, Schellhammer PF. Davis JW, et al. J Urol. 1999 Sep;162(3 Pt 1):758-61. doi: 10.1097/00005392-199909010-00036. J Urol. 1999. PMID: 10458360

4

Quality of life after treatment for localized prostate cancer: differences based on treatment modality.

Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Davis JW, et al. Among authors: kuban da. J Urol. 2001 Sep;166(3):947-52. J Urol. 2001. PMID: 11490252

5

Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation.

Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Urol. 2002 Aug;168(2):536-41. J Urol. 2002. PMID: 12131304

6

Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer.

Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Urol. 2002 Nov;168(5):2001-5. doi: 10.1016/S0022-5347(05)64282-6. J Urol. 2002. PMID: 12394695

7

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA. Huang EH, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1314-21. doi: 10.1016/s0360-3016(02)03742-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459352

8

Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.

Hung AY, Levy L, Kuban DA. Hung AY, et al. Among authors: kuban da. Cancer J. 2002 Nov-Dec;8(6):440-4. doi: 10.1097/00130404-200211000-00007. Cancer J. 2002. PMID: 12500852

9

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma.

Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL. Rosser CJ, et al. Among authors: kuban da. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):1-6. doi: 10.1016/s0360-3016(02)04468-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694817

10

Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate.

Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Rosser CJ, et al. Among authors: kuban da. J Urol. 2003 Jun;169(6):2160-5. doi: 10.1097/01.ju.0000058212.00170.a0. J Urol. 2003. PMID: 12771739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters